Albany Molecular Research has announced it’s been chosen to support the development and manufacture of lipid excipients for the Pfizer-BioNTech COVID-19 vaccine. The lipid excipient surrounds and protects the vaccine’s active ingredient.
For the past several months, AMRI has been providing development, scale-up and manufacturing services at several of its global R&D and production sites.
“We are proud to support Pfizer and BioNTech in this global effort to halt the spread of COVID-19 and prevent further occurrence of this devastating disease,” said John Ratliff, CEO, AMRI.
“Our response to this pandemic will continue to be both rapid and reliable, reflecting our dedication to quality delivery and scientific integrity. We are committed to playing a vital role in ending this pandemic, from our work in support of antivirals and vaccines to the continued production of essential medicines used for COVID-19 patients.”
